Your prediction
Pros and Cons of Taro Pharmaceutical Industries Ltd in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Taro Pharmaceutical Industries Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Taro Pharmaceutical Industries Ltd | - | - | - | - | - | - | - |
| Repligen Corp. | 2.370% | 5.620% | 4.583% | 24.380% | -9.265% | -18.077% | -39.114% |
| Opko Health Inc. | 1.800% | 6.604% | -10.317% | 8.321% | 3.651% | -31.140% | -61.235% |
| Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. | 0.580% | 0.000% | 6.135% | -12.626% | -11.735% | -33.462% | -24.123% |
Comments
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Show more
Ratings data for TARO provided by MarketBeat
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Show more
Ratings data for TARO provided by MarketBeat
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Show more
Ratings data for TARO provided by MarketBeat